CEO Urges $31 Million Investment In Malaysia Biotech Sector
This article was originally published in PharmAsia News
Executive Summary
A biotech CEO says Malaysia needs as much as $31 million in public-sector investment within the next three years if the industry is to reach a commercialization level. Datuk Iskandar Mizal Mahmood, CEO of Malaysian Biotech, spoke of a need of $25 million to $31 million to build an infrastructure and collaborate with foreign entities to leverage the nation's tissue-banking sector. He said Malaysia needs to make a strong effort to complement the efforts of the National Tissue Bank and Nuklear Malaysia to commercialize tissue banking as part of a huge global market for tissue-engineered products. (Click here for more